| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | Chief Development Officer
1 company
Longpre Lara is a Chief Development Officer at Mirum Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 1 buy and 5 sells.
Estimated insider holdings value: $10.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2024 | MIRM Mirum Pharmaceuticals, Inc. | Chief Development Officer | Sell | 847 | $26.19 | $22,184.45 | -0.8% | -3.5% | +84.3% | |
| Jan 8, 2024 | MIRM Mirum Pharmaceuticals, Inc. | Chief Development Officer | Sell | 1,019 | $28.04 | $28,567.67 | -1.0% | -9.1% | +47.5% | |
| Jul 3, 2023 | MIRM Mirum Pharmaceuticals, Inc. | Chief Development Officer | Sell | 1,004 | $25.65 | $25,749.19 | -0.9% | +14.2% | +31.3% | |
| Jan 9, 2023 | MIRM Mirum Pharmaceuticals, Inc. | Chief Development Officer | Sell | 1,003 | $20.62 | $20,684.17 | -1.0% | +24.7% | +39.4% | |
| Oct 1, 2021 | MIRM Mirum Pharmaceuticals, Inc. | Chief Development Officer | Sell | 961 | $19.26 | $18,505.02 | -1.1% | -18.8% | +8.6% | |
| Sep 10, 2019 | MIRM Mirum Pharmaceuticals, Inc. | Chief Development Officer | Buy | 965 | $10.64 | $10,267.60 | +0.9% | - | - |